Search

everythinglearnresearchcommunity

for

Search:↓

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Auto-portraits help evaluate scalp hair.

Alopecia linked to higher anxiety and personality disorders.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Minoxidil helps hair regrowth in alopecia areata safely.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.